Pharmafile Logo
Pharmafocus logo
Advanced Search

Eli Lilly

Showing 15 posts of 212 posts found.

FDA approves another indication for Lilly/Boehringer diabetes treatment

December 5, 2016
Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance

Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …

News
lilly2_web

Lilly forced to abandon Alzheimer’s drug after failed trial

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …

News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …

News
lilly_corporate_hq

Lilly announces plan to expand global access to health care

October 19, 2016
Research and Development Eli Lilly, Lilly 30x30, global health

Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …

News
novartis_building

Novartis’ new drug muscles in on Pfizer’s territory

October 10, 2016
Sales and Marketing Eli Lilly, Novartis, Pfizer, ibrance, ribociclib

A drug developed by Novartis, ribociclib, when combined with an older drug, letrozole, has been shown to reduce risk of progression …

News
lilly_entrance_web

EU recommendation for Lilly’s soft tissue cancer drug

September 19, 2016
Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma

The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …

News
eli_lilly_logo

Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …

Appointment

Eli Lilly elects Jamere Jackson to board of directors

September 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …

Appointment
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …

Appointment
lilly_corporate_hq

Interim analysis fails to show benefits for Lilly’s abemaciclib in advanced breast cancer

August 10, 2016
Research and Development Eli Lilly, abemaciclib, breast cancer

Eli Lilly has announced that, after a pre-planned interim analysis for their Phase III MONARCH2 trial, investigators have decided to …

News
johnnolech

John Lechleiter to step down as Lilly CEO

July 27, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, John Lechleiter

Eli Lilly has announced that CEO John Lechleiter is set to retire, with David Ricks to assume the role as …

News
headquarters_2_web

Eli Lilly Q2 2016 results surpass estimates

July 27, 2016
Research and Development, Sales and Marketing Eli Lilly, financial report

Eli Lilly has released its financial report for the second quarter of 2016, noting a number of promising results.  The …

News
cancerstudy

Lilly, Boehringer Ingelheim to jointly study combination therapy for breast cancer

July 14, 2016
Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, breast cancer, combination therapy, drug trial

US drug major Eli Lilly (NYSE: LLY) and Boehringer Ingelheim said they will jointly initiate early combination trials in breast cancer. The …

News
eli_lilly_logo

Eli Lilly says FDA panel backs approval of Jardiance for cardiovascular indication

June 30, 2016
Research and Development, Sales and Marketing Eli Lilly, cardiovascular, diabetes, jardiance

US drugmaker Eli Lilly (NYSE: LLY) said a US regulatory panel has backed its Jardiance (empagliflozin) for reducing cardiovascular death …

News
lilly_entrance_web

German Supreme Court grants Lilly appeal to block Alimta generics

June 15, 2016
Research and Development, Sales and Marketing Actavis, Alimta, Eli Lilly

Eli Lilly (NYSE: LLY) has announced that it has been granted an appeal by the German Federal Supreme Court, in …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024